Febuxostat for Tumor Lysis Syndrome Prevention in Hematological Malignancies of Paediatric Patients and Adults
Clinical trial NCT03605212 · TERMINATED
Trial details
- NCT number
- NCT03605212
- Sponsor
- Menarini Group
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-27
- Primary completion
- 2018-07-25
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.